CEBPD and neoplasm: The nine prognostic TANRGs, including TAGLN2, IGF2R, LAMP2, TBL1X, ASAP1, DENND5A, SNRK, BCL3, and CEBPD, were determined as promising TAN-related biomarkers correlated with the prognosis, tumor immunity and treatment outcomes in BRCA patients.